Shanghai Haohai Biological Technology Management
Management Kriterienprüfungen 4/4
Shanghai Haohai Biological Technology's CEO ist Jianying Wu , ernannt in Jul 2010, hat eine Amtszeit von 14.08 Jahren. besitzt direkt 4.76% der Aktien des Unternehmens, im Wert von HK$658.30M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 9.7 Jahre bzw. 10.8 Jahre.
Wichtige Informationen
Jianying Wu
Geschäftsführender
CN¥1.9m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | n/a |
| Amtszeit als Geschäftsführer | 14.2yrs |
| Eigentum des Geschäftsführers | 3.7% |
| Durchschnittliche Amtszeit des Managements | 9.8yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 10.9yrs |
Jüngste Management Updates
Recent updates
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Can Mixed Fundamentals Have A Negative Impact on Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Current Share Price Momentum?
Feb 23Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥446m |
| Mar 31 2024 | n/a | n/a | CN¥432m |
| Dec 31 2023 | CN¥2m | n/a | CN¥416m |
| Sep 30 2023 | n/a | n/a | CN¥346m |
| Jun 30 2023 | n/a | n/a | CN¥315m |
| Mar 31 2023 | n/a | n/a | CN¥226m |
| Dec 31 2022 | CN¥2m | CN¥855k | CN¥180m |
| Sep 30 2022 | n/a | n/a | CN¥203m |
| Jun 30 2022 | n/a | n/a | CN¥192m |
| Mar 31 2022 | n/a | n/a | CN¥272m |
| Dec 31 2021 | CN¥1m | CN¥845k | CN¥352m |
| Sep 30 2021 | n/a | n/a | CN¥428m |
| Jun 30 2021 | n/a | n/a | CN¥434m |
| Mar 31 2021 | n/a | n/a | CN¥370m |
| Dec 31 2020 | CN¥1m | CN¥768k | CN¥230m |
| Sep 30 2020 | n/a | n/a | CN¥232m |
| Jun 30 2020 | n/a | n/a | CN¥216m |
| Mar 31 2020 | n/a | n/a | CN¥279m |
| Dec 31 2019 | CN¥2m | CN¥742k | CN¥371m |
| Sep 30 2019 | n/a | n/a | CN¥353m |
| Jun 30 2019 | n/a | n/a | CN¥386m |
| Mar 31 2019 | n/a | n/a | CN¥375m |
| Dec 31 2018 | CN¥1m | CN¥712k | CN¥415m |
| Sep 30 2018 | n/a | n/a | CN¥411m |
| Jun 30 2018 | n/a | n/a | CN¥408m |
| Mar 31 2018 | n/a | n/a | CN¥390m |
| Dec 31 2017 | CN¥1m | CN¥583k | CN¥372m |
Vergütung im Vergleich zum Markt: JianyingDie Gesamtvergütung ($USD267.02K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Hong Kong ($USD588.16K).
Entschädigung vs. Einkommen: JianyingDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Jianying Wu (60 yo)
14.2yrs
Amtszeit
CN¥1,904,800
Vergütung
Dr. Jianying Wu has been General Manager of Shanghai Haohai Biological Technology Co., Ltd. since July 23, 2010 and has been its Executive Director since December 2014. Mr. Wu served as a Director at Shang...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Executive Chairman | 14.2yrs | CN¥1.89m | 3.64% CN¥ 509.9m | |
| GM & Executive Director | 14.2yrs | CN¥1.90m | 3.67% CN¥ 515.1m | |
| CFO & Executive Director | 7.8yrs | CN¥1.45m | 0.036% CN¥ 5.1m | |
| Executive Director | 9.8yrs | CN¥1.26m | 0.26% CN¥ 36.0m | |
| Joint Company Secretary | 4.8yrs | CN¥868.70k | 0.0044% CN¥ 617.1k | |
| Deputy General Manager | 10yrs | CN¥912.50k | 0.012% CN¥ 1.7m | |
| Joint Company Secretary | 9.8yrs | keine Daten | keine Daten |
9.8yrs
Durchschnittliche Betriebszugehörigkeit
49yo
Durchschnittliches Alter
Erfahrenes Management: 6826Das Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (9.7 ).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Executive Chairman | 14.2yrs | CN¥1.89m | 3.64% CN¥ 509.9m | |
| GM & Executive Director | 14.2yrs | CN¥1.90m | 3.67% CN¥ 515.1m | |
| CFO & Executive Director | 7.6yrs | CN¥1.45m | 0.036% CN¥ 5.1m | |
| Executive Director | 14.2yrs | CN¥1.26m | 0.26% CN¥ 36.0m | |
| Independent Non-Executive Director | less than a year | keine Daten | keine Daten | |
| Non Executive Director | 14.2yrs | keine Daten | 47.2% CN¥ 6.6b | |
| Non-Executive Director | 14.2yrs | CN¥150.00k | 1.21% CN¥ 169.8m | |
| Chairman of the Supervisory Committee | 14.2yrs | keine Daten | 1.21% CN¥ 169.8m | |
| Independent Non-Executive Director | 4.3yrs | CN¥150.00k | keine Daten | |
| Independent Non-Executive Director | 4.3yrs | CN¥150.00k | keine Daten | |
| Independent Non-Executive Director | 4.3yrs | CN¥150.00k | keine Daten | |
| Independent Non-Executive Director | 4.3yrs | CN¥150.00k | keine Daten |
10.9yrs
Durchschnittliche Betriebszugehörigkeit
52.5yo
Durchschnittliches Alter
Erfahrener Vorstand: 6826Die Vorstandsmitglieder sind sehr erfahren ( 10.8 ).